Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms
- 5 January 1998
- journal article
- Published by Elsevier
- Vol. 31 (1-2) , 95-112
- https://doi.org/10.1016/s0167-5877(96)01119-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Multidrug-Resistant Enterococcus faeciumDrugs, 1994
- Phenotypic identification of the genus Enterococcus and differentiation of phylogenetically distinct enterococcal species and species groupsJournal of Applied Bacteriology, 1993
- Emergence of vancomycin-resistant enterococci in New York CityThe Lancet, 1993
- Vancomycin-Resistant Enterococcus faecium: Headline NewsInfection Control & Hospital Epidemiology, 1992
- Major trends in the microbial etiology of nosocomial infectionThe American Journal of Medicine, 1991
- The enterococci: An enigma and a continuing therapeutic challengeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988
- The effect of growth‐promoting antibiotics on the faecal enterococci of healthy young chickensJournal of Applied Bacteriology, 1988
- Observations on thein vitrosensitivity and resistance of Gram positive intestinal bacteria of farm animals to growth promoting antimicrobial agentsJournal of Applied Bacteriology, 1984
- The Effect of Dietary Avoparcin on the Antibiotic Resistance Patterns of Enteric and Pharyngeal Bacteria Isolated from Broiler ChickensZentralblatt für Veterinärmedizin Reihe B, 1978